| |||||||||||||||||
|
Media and other industry stakeholders can access current top-line U.S. and global pharmaceutical trends for use in story development or vital health research initiatives. Key indicators include: leading companies, leading products, leading therapeutic classes and leading channels of distribution–as measured by prescription sales and dispensing.
To ensure the integrity of our information, we have included the proper sourcing attribution, and have listed pertinent caveats and footnotes for each chart. Questions should be directed to Gary Gatyas of the IMS Communications Department.
Note: IMS Retail Drug Monitor covers 13 key global markets.
2008 Top-Line Industry Data
2007 Top-Line Industry Data
2006 Top-Line Industry Data
2005 Top-Line Industry Data
2004 Top-Line Industry Data
2003 Top-Line Industry Data
2002 Top-Line Industry Data
2001 Top-Line Industry Data
2000 Top-Line Industry Data
 |
|
IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion Click here to read the press release. Click here for accompanying charts. |
 |
|
IMS Health Reports Global Prescription Sales Grew 6.4 Percent in 2007, to $712 Billion Click here to read the press release. Click here for accompanying charts. |
